Academic Medical Center
Appears in 1 story
Conducting ongoing Phase 2 cancer vaccine trials
Metastatic breast cancer typically kills most patients within five years. A small group of women vaccinated in a Duke University clinical trial two decades ago have defied that prognosis entirely—all remain alive today. Researchers discovered these survivors still carry specialized immune cells capable of recognizing their cancer—evidence of a mechanism that could make therapeutic cancer vaccines work reliably.
Updated May 23
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
